16.11.2023 09:33:27
|
Kilitch Healthcare Recalls Eye Drops Sold Through Walmart, Target, CVS
(RTTNews) - Mumbai, Maharashtra-based Kilitch Healthcare India Ltd. is recalling various eye drops under multiple labels sold through Walmart, Target, and CVS due to potential safety concerns, according to the U.S Food and Drug Administration or FDA.
The recall was initiated when the agency investigators found insanitary conditions.
The recall involves all lots within expiry with expiration dates ranging from November, 2023 to September, 2025.
The called-back products were distributed nationwide to wholesalers, retailers and via product distributor, Velocity Pharma LLC.
The affected lubricant eye drops & multi-symptom eye drops were sold through various retailers and labels including Walmart, Rugby, Target, Rite Aid, Leader, Velocity and CVS.
The patients who used these impacted products run a potential risk of eye infections or related harm. These products are intended to be sterile and such ophthalmic drug products may pose heightened risk of harm because drugs applied to the eyes bypass some of the body's natural defenses.
So far, the pharmaceutical company has not received any reports of adverse events related to the recall.
FDA is urging the consumers to stop using the recalled eye drops and instead return to the place of purchase.
In similar recalls, Cardinal Health, Inc. earlier this month recalled certain Leader branded eye drops supplied by Velocity Pharma citing potential risk of eye infections.
Phoenix, Arizona-based Pharmedica USA LLC in March recalled Purely Soothing, 15 percent MSM eye drops to the consumer level due to non-sterility.
In mid- September, the FDA had warned eight companies including CVS Health and Walgreens Boots Alliance, Inc. against manufacturing or marketing unapproved ophthalmic drug products in violation of federal law.
For More Such Health News, visit rttnews.com
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Walmartmehr Nachrichten
01.01.25 |
Dow Jones 30 Industrial-Wert Walmart-Aktie: So viel hätten Anleger mit einem Investment in Walmart von vor 10 Jahren verdient (finanzen.at) | |
31.12.24 |
Dow Jones-Handel aktuell: Dow Jones zeigt sich schwächer (finanzen.at) | |
27.12.24 |
Zurückhaltung in New York: Dow Jones notiert zum Handelsende im Minus (finanzen.at) | |
27.12.24 |
Zurückhaltung in New York: Das macht der Dow Jones aktuell (finanzen.at) | |
27.12.24 |
Börse New York in Rot: Dow Jones verliert zum Start (finanzen.at) | |
26.12.24 |
Starker Wochentag in New York: Am Donnerstagnachmittag Gewinne im Dow Jones (finanzen.at) | |
25.12.24 |
Dow Jones 30 Industrial-Papier Walmart-Aktie: So viel Gewinn hätte ein Investment in Walmart von vor 5 Jahren eingefahren (finanzen.at) | |
24.12.24 |
Optimismus in New York: Dow Jones zum Ende des Dienstagshandels auf grünem Terrain (finanzen.at) |
Analysen zu Walmartmehr Analysen
05.12.24 | Walmart Buy | UBS AG | |
20.11.24 | Walmart Halten | DZ BANK | |
20.11.24 | Walmart Buy | Goldman Sachs Group Inc. | |
20.11.24 | Walmart Buy | Jefferies & Company Inc. | |
20.11.24 | Walmart Buy | UBS AG |
Aktien in diesem Artikel
CVS Health Corp | 43,01 | -0,96% | |
Target Corp. | 133,42 | 0,18% | |
Walmart | 87,62 | 0,08% |